Omalizumab in Patients With Antihistamine-Resistant CSU

British Journal of Dermatology - United Kingdom
doi 10.1111/bjd.17368
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Antinuclear Antibodies Are Common and Linked to Poor Response to Omalizumab Treatment in Patients With CSU

Allergy: European Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Are Currently Available Biomarkers Useful to Discriminate CSU Patients Not Controlled by Low Dose Omalizumab Maintenance Therapy?

European Annals of Allergy and Clinical Immunology
AllergyImmunology
2020English

Omalizumab Treatment in Patients With Chronic Spontaneous Urticaria

Bőrgyógyászati és Venerológiai Szemle
2015English

Omalizumab in Patients With Severe Asthma and Persistent Sputum Eosinophilia

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Efficacy of Omalizumab in Treatment-Resistant Chronic Spontaneous Urticaria

Asim, Allerji, Immunoloji
Respiratory MedicinePulmonaryAllergyImmunology
2018English

Appropriate Selection for Omalizumab Treatment in Patients With Severe Asthma?

European Clinical Respiratory Journal
2017English

Effects of Omalizumab on Blood Eosinophil Numbers in Patients With Allergic Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Transient Hair Loss in Patients With Chronic Spontaneous Urticaria Treated With Omalizumab

European Annals of Allergy and Clinical Immunology
AllergyImmunology
2017English

Strategies for Discontinuing Omalizumab in Patients With Chronic Urticaria: Real-World Findings

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy